DORIS DUKE CHARITABLE FOUNDATION (DDCF)
\n2023 REQUEST FOR APPLICATIONS
\nCLINICAL SCIENTIST DEVELOPMENT AWARD<\/p>\n
GRANT OPPORTUNITY
\nApproximately 16 grants of up to $495,000 each over 3 years ($150,000 direct cost and $15,000 indirect costs per year) will be awarded to early-career physician scientists (MD, MD\/PhD, DO or foreign equivalent degree) at the Assistant Professor rank working at US degree-granting institutions to support clinical research that will enable their transition to independent research funding.<\/p>\n
KEY DATES
\nExemption request deadline October 14, 2022, 5 pm ET
\nPre-proposal applications due November 17, 2022, 3 pm ET
\nInvitation to submit a full proposal January 17, 2023
\nFull proposal due March 14, 2023, 3 pm ET
\nNotice of Award End of May 2023
\nAward Start Date July 1, 2023<\/p>\n
PROGRAM DESCRIPTION
\nPhysician scientists pursuing research careers face challenges that are particular to their dual roles as researchers and health care providers. The purpose of the Doris Duke Clinical Scientist Development Award (CSDA) is to enable Assistant Professor rank physician scientists\u2019 achievement of independent and successful research careers by providing support to: 1) conduct an outstanding clinical research project with high significance and potential to improve human health, 2) enable research time protection to ease the tension between research and clinical\u00a0 responsibilities, and 3) facilitate development of strong mentorship relations in a supportive institutional environment. Ultimately, investigators supported by the CSDA program are expected to advance human health by driving insights into mechanisms of disease, improvements to patient care and population health, whether in the near or long term.<\/p>\n
AWARD INFORMATION
\nThe 2023 Clinical Scientist Development Award consists of $150,000 annual direct costs plus $15,000 (10%) annual indirect costs for three years. The award project period is July 1, 2023 - June 30, 2026. DDCF expects to fund approximately 16 applications in 2023. The priority of the CSDA program is to support outstanding individuals whose projects will address highly significant research questions to advance human health and with promise for sustained clinical research careers. For this program, DDCF does not have funding priorities based on disease area or research type.<\/p>\n